Symbiotix Biotherapies, Inc. (“Symbiotix”), a pioneering venture-backed microbiome company developing novel molecular therapeutics based on the human microbiome, today announced that it has entered into a license agreement with Harvard University. Under the agreement, Symbiotix […]
AOBiome Therapeutics (“AOBiome”), a clinical-stage life sciences company advancing patented microbiome-targeted therapies, today announced clinical findings from Part 1 of a Phase 1b/2a clinical trial of the Company’s first-in-class Ammonia Oxidizing Bacteria (AOB) product candidate […]
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced the results of a new study investigating the preventive effects of its new probiotic strain Bifidobacterium breve A1 on a model […]
The Biocodex Microbiota Foundation (BMF), an organization founded by Biocodex North America and dedicated to inspiring scientific projects that explore the structure of microbiota, has announced two winners – Dr. Rashim Singh from the United […]
Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company, today announced that it has achieved two key technology milestones in its High Fiber Resistant Starch (RS) Wheat program. First, through advanced screening and traditional breeding […]
CosmosID, provider of leading products and services to unlock the microbiome accurately and actionably, is proud to announce that Dr. Arne Materna is joining its Senior Leadership team as Vice President of Product. Dr. Materna’s […]
Prevalence of Chronic Kidney Illness in India is 17.2% and rising (Singh AK, Farag YM, Mittal BV, et al. Epidemiology and risk factors of chronic kidney disease in India– results from the SEEK (Screening and […]
MyBiotics Pharma Ltd., a microbiome therapeutics company, announced today that it has entered into a second option agreement with Ferring Holding Ltd. for the validation of MyBiotics’ microbiome-based therapeutics in the field of women’s health. […]
Prairie-grown potatoes have been enjoyed across Canada for years, and now through a patented technology a Manitoba company is transforming the popular tubers into an all-natural, single ingredient prebiotic fibre supplement that leads to improved […]
Second Genome, Inc., a leader in the development of novel medicines derived from the human microbiome, today announced the initiation of four collaborations with key academic institutions to evaluate the effect of gut microbiota on […]
Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, today provided a clinical programs update and reported financial results for […]